Multiple Myeloma
Featured Articles
(Yahoo! Finance) Mar 26, 2019 - First DARZALEX combination treatment regimen being pursued in the frontline setting for transplant eligible patients with multiple myeloma. The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food...
Read Article
(Reuters) Mar 21, 2019 - GlaxoSmithKline received a boost for its oncology research on Thursday, as it reported further positive data from a study of its experimental drug for blood cancer. The DREAMM-1 study of patients with relapsed/refractory multiple myeloma confirmed the potential effectiveness of the medicine, GSK said.
Read Article
Latest Articles
April 16, 2019
April 09, 2019
April 05, 2019
April 04, 2019
April 03, 2019
April 03, 2019
April 02, 2019
April 01, 2019
View More
News Commentary
There is no Multiple Myeloma commentary.

OBR Green
There are no Multiple Myeloma OBR Green articles.
OBR Blog
As the ASH Annual Meeting concludes, the late-breaking abstracts are always of great interest. We take a brief look at... Read more
December 04, 2018